BACKGROUND AND AIM: Nonalcoholic fatty liver disease (NAFLD) is strongly associated with obesity, hyperlipidemia, and type 2 diabetes mellitus. Several studies have found that fat mass and the obesity-associated (FTO) gene is linked to obesity. The aim of this work is to investigate the expression and function of FTO in liver with lipid metabolism diseases. METHODS: We investigated the basal FTO expression in an NAFLD rat model and compared it with control subjects. The function of FTO in lipid metabolism was further studied in L02 cells through overexpression experiments. RESULTS: A significant increase in FTO mRNA and protein levels was found in the NAFLD group. In addition, the FTO levels were positively associated with malondialdehyde and superoxide dismutase concentrations. FTO overexpression in L02 cells enhanced lipogenesis and oxidative stress. CONCLUSIONS: This study demonstrates that increased FTO levels in the liver are involved in oxidative stress and lipid deposition, which characterize NAFLD.
BACKGROUND AND AIM: Nonalcoholic fatty liver disease (NAFLD) is strongly associated with obesity, hyperlipidemia, and type 2 diabetes mellitus. Several studies have found that fat mass and the obesity-associated (FTO) gene is linked to obesity. The aim of this work is to investigate the expression and function of FTO in liver with lipidmetabolism diseases. METHODS: We investigated the basal FTO expression in an NAFLD rat model and compared it with control subjects. The function of FTO in lipid metabolism was further studied in L02 cells through overexpression experiments. RESULTS: A significant increase in FTO mRNA and protein levels was found in the NAFLD group. In addition, the FTO levels were positively associated with malondialdehyde and superoxide dismutase concentrations. FTO overexpression in L02 cells enhanced lipogenesis and oxidative stress. CONCLUSIONS: This study demonstrates that increased FTO levels in the liver are involved in oxidative stress and lipid deposition, which characterize NAFLD.
Authors: Tuomas O Kilpeläinen; Marcel den Hoed; Ken K Ong; Anders Grøntved; Soren Brage; Karen Jameson; Cyrus Cooper; Kay-Tee Khaw; Ulf Ekelund; Nicholas J Wareham; Ruth J F Loos Journal: Am J Clin Nutr Date: 2011-01-19 Impact factor: 7.045
Authors: Julia Fischer; Linda Koch; Christian Emmerling; Jeanette Vierkotten; Thomas Peters; Jens C Brüning; Ulrich Rüther Journal: Nature Date: 2009-02-22 Impact factor: 49.962
Authors: Leon A Adams; Oliver R Waters; Matthew W Knuiman; Robert R Elliott; John K Olynyk Journal: Am J Gastroenterol Date: 2009-03-17 Impact factor: 10.864
Authors: Timothy M Frayling; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Rachel M Freathy; Cecilia M Lindgren; John R B Perry; Katherine S Elliott; Hana Lango; Nigel W Rayner; Beverley Shields; Lorna W Harries; Jeffrey C Barrett; Sian Ellard; Christopher J Groves; Bridget Knight; Ann-Marie Patch; Andrew R Ness; Shah Ebrahim; Debbie A Lawlor; Susan M Ring; Yoav Ben-Shlomo; Marjo-Riitta Jarvelin; Ulla Sovio; Amanda J Bennett; David Melzer; Luigi Ferrucci; Ruth J F Loos; Inês Barroso; Nicholas J Wareham; Fredrik Karpe; Katharine R Owen; Lon R Cardon; Mark Walker; Graham A Hitman; Colin N A Palmer; Alex S F Doney; Andrew D Morris; George Davey Smith; Andrew T Hattersley; Mark I McCarthy Journal: Science Date: 2007-04-12 Impact factor: 47.728
Authors: Pawel K Olszewski; Robert Fredriksson; Agnieszka M Olszewska; Olga Stephansson; Johan Alsiö; Katarzyna J Radomska; Allen S Levine; Helgi B Schiöth Journal: BMC Neurosci Date: 2009-10-27 Impact factor: 3.288
Authors: Zaid O Ibraheem; Rusliza Basir; Ahmad Kh Aljobory; Omar E Ibrahim; Ajwad Alsumaidaee; Mun Fee Yam Journal: Biomed Res Int Date: 2014-06-23 Impact factor: 3.411
Authors: Daniel Pineda-Tenor; Juan Berenguer; María A Jiménez-Sousa; Mónica García-Alvarez; Teresa Aldámiz-Echevarria; Ana Carrero; Sonia Vázquez-Morón; Pilar García-Broncano; Cristina Diez; Francisco Tejerina; María Guzmán-Fulgencio; Salvador Resino Journal: BMC Med Date: 2014-11-03 Impact factor: 8.775